BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29394665)

  • 1. [Subtotal Esophagectomy for Mediastinal Lymph Node Oligo-Recurrence of ALK-Positive Lung Adenocarcinoma - A Case Report].
    Tetsumoto S; Okada K; Nagata H; Toyota S; Tanaka S; Niki T; Tsuruta N; Higaki N; Niju T; Oka Y; Nezu R; Ikeda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1452-1454. PubMed ID: 29394665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report.
    Shirasawa M; Kubotaa M; Harada S; Niwa H; Kusuhara S; Kasajima M; Hiyoshi Y; Ishihara M; Igawa S; Masuda N
    Lung Cancer; 2016 Sep; 99():66-8. PubMed ID: 27565916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].
    Caliez J; Monnet I; Pujals A; Rousseau-Bussac G; Jabot L; Boudjemaa A; Leroy K; Chouaid C
    Rev Mal Respir; 2017 May; 34(5):576-580. PubMed ID: 27646667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidermal Growth Factor Receptor-mutated Advanced Lung Adenocarcinoma with Long-term Tumor-free Survival by Chemotherapy Followed by Tyrosine Kinase Inhibitor Treatment after Reduction Surgery].
    Morio A; Nakahara K; Futagawa T; Suzuki K
    Kyobu Geka; 2016 Dec; 69(13):1051-1054. PubMed ID: 27909271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Feasibility and safety of radical mediastinal lymphadenectomy in thoracoscopic esophagectomy for esophageal cancer].
    Zhang Y; Tan LJ; Feng MX; Wang H; Wang Q
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):855-9. PubMed ID: 23291137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe acute interstitial lung disease in a patient with anaplastic lymphoma kinase rearrangement-positive non-small cell lung cancer treated with alectinib.
    Yamamoto Y; Okamoto I; Otsubo K; Iwama E; Hamada N; Harada T; Takayama K; Nakanishi Y
    Invest New Drugs; 2015 Oct; 33(5):1148-50. PubMed ID: 26334220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.
    Zhang S; Yan B; Zheng J; Zhao J; Zhou J
    Oncotarget; 2016 Sep; 7(39):63758-63766. PubMed ID: 27563816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].
    Ota S; Inaba H; Yoshida H
    Kyobu Geka; 2001 Dec; 54(13):1073-8; discussion 1078-81. PubMed ID: 11761888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma.
    Rosoux A; Pauwels P; Duplaquet F; D'Haene N; Weynand B; Delos M; Menon R; Heukamp LC; Thunnissen E; Ocak S
    Lung Cancer; 2016 Aug; 98():118-121. PubMed ID: 27393517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
    Dubey AP; Pathi N; Viswanath S; Rathore A; Pathak A; Sud R
    Indian J Cancer; 2017; 54(1):203-208. PubMed ID: 29199691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.
    Watanabe S; Hayashi H; Okamoto K; Fujiwara K; Hasegawa Y; Kaneda H; Tanaka K; Takeda M; Nakagawa K
    Clin Lung Cancer; 2016 Nov; 17(6):528-534. PubMed ID: 27318655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Advanced Esophagogastric Junction Adenocarcinoma with Enlarged Lymph Node Metastases of the Middle Mediastinum and Intraperitoneal That Exhibited pCR by Preoperative SOX Therapy].
    Mita K; Oda H; Sato M; Takahashi K; Shimaguchi M; Kobayashi N; Kouno M; Toyota T; Toyota N; Hatano M; Sasaki J; Kawamura Y; Nishida K
    Gan To Kagaku Ryoho; 2023 Aug; 50(8):909-912. PubMed ID: 37608419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after three-field lymph-adenectomy for an adenocarcinoma in Barrett's esophagus with metastasis to Virchow's node.
    Matono S; Fujita H; Sueyoshi S; Tanaka T; Yamana H; Shirouzu K
    Jpn J Thorac Cardiovasc Surg; 2006 Jan; 54(1):11-5. PubMed ID: 16482930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Therapy with Crizotinib and Alectinib in ALK-Rearranged Non-Small Cell Lung Cancer-A Multicenter Retrospective Study.
    Ito K; Hataji O; Kobayashi H; Fujiwara A; Yoshida M; D'Alessandro-Gabazza CN; Itani H; Tanigawa M; Ikeda T; Fujiwara K; Fujimoto H; Kobayashi T; Gabazza EC; Taguchi O; Yamamoto N
    J Thorac Oncol; 2017 Feb; 12(2):390-396. PubMed ID: 27498387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung adenocarcinoma with multiple pulmonary metastases completely responsive to combination chemotherapy with carboplatin and weekly paclitaxel--a case report].
    Ishida T; Tomiyasu M; Kohso H; Iwanami T; Ikegami T; Okazaki J; Emi Y; Kido A; Ezaki T
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1313-6. PubMed ID: 14518412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features and Therapeutic Responses of Chinese Patients with Advanced Lung Adenocarcinoma Harboring an Anaplastic Lymphoma Kinase Rearrangement.
    Lin D; Zeng D; Chen C; Wu X; Wang M; Chen J; Lin H; Qiu X
    Oncol Res Treat; 2017; 40(1-2):27-33. PubMed ID: 28118634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case of double primary lung adenocarcinomas with an EGFR mutation and ALK translocation successfully treated with alectinib at the post-surgical recurrence.
    Tsunezuka Y; Tanaka N; Fujimori H; Togashi Y; Baba S; Takeuchi K; Katayanagi K; Kurumaya H; Kitade H; Atagi S; Yano S
    J Med Invest; 2017; 64(3.4):305-307. PubMed ID: 28955002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advanced lung cancer with mediastinal lymph node metastasis and recurrence of brain metastasis completely responsive to combination chemotherapy and gamma knife radiosurgery--a case report].
    Higaki N; Soma I; Hayashi N; Nakano K; Murakami M; Hayashida H; Kan K; Ichihara T; Aizawa N; Saito N; Niju T; Ikeda T; Sakon M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2111-3. PubMed ID: 20037340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma.
    Kamide Y; Kaira K; Watanabe T; Kuribayashi S; Ozawa A; Koga Y; Ono A; Sunaga N; Hisada T; Oyama T; Yamada M
    Intern Med; 2015; 54(22):2905-9. PubMed ID: 26568007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.
    Isozaki H; Yasugi M; Takigawa N; Hotta K; Ichihara E; Taniguchi A; Toyooka S; Hashida S; Sendo T; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2014 Oct; 44(10):963-8. PubMed ID: 25170107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.